Waldman SA - Search Results

1

Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarin.

Kong AN, Tomasko L, Waldman SA, Osborne B, Deutsch PJ, Goldberg MR, Bjornsson TD. Kong AN, et al. Among authors: waldman sa. J Clin Pharmacol. 1995 Oct;35(10):1008-15. doi: 10.1002/j.1552-4604.1995.tb04018.x. J Clin Pharmacol. 1995. PMID: 8568008 Clinical Trial.

2

Effects of food on the bioequivalence of different verapamil sustained-release formulations.

Waldman SA, Morganroth J. Waldman SA, et al. J Clin Pharmacol. 1995 Feb;35(2):163-9. doi: 10.1002/j.1552-4604.1995.tb05006.x. J Clin Pharmacol. 1995. PMID: 7751427 Clinical Trial.

3

Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.

Goldberg MR, Bradstreet TE, McWilliams EJ, Tanaka WK, Lipert S, Bjornsson TD, Waldman SA, Osborne B, Pivadori L, Lewis G, et al. Goldberg MR, et al. Among authors: waldman sa. Hypertension. 1995 Jan;25(1):37-46. doi: 10.1161/01.hyp.25.1.37. Hypertension. 1995. PMID: 7843751 Clinical Trial.

4

Hypotensive mechanisms of amifostine.

Ryan SV, Carrithers SL, Parkinson SJ, Skurk C, Nuss C, Pooler PM, Owen CS, Lefer AM, Waldman SA. Ryan SV, et al. Among authors: waldman sa. J Clin Pharmacol. 1996 Apr;36(4):365-73. doi: 10.1002/j.1552-4604.1996.tb04214.x. J Clin Pharmacol. 1996. PMID: 8728352

5

Pharmacokinetics and pharmacodynamics of tepoxalin after single oral dose administration to healthy volunteers.

Waldman SA, Vitow C, Osborne B, Gillen L, Argentieri DC, Wong FA, Smith IL, Chow AT, Misiti J, Bjornsson TD. Waldman SA, et al. J Clin Pharmacol. 1996 May;36(5):462-8. doi: 10.1002/j.1552-4604.1996.tb05033.x. J Clin Pharmacol. 1996. PMID: 8739025 Clinical Trial.

6

Paradoxical hypotension and bradycardia after intravenous arginine vasopressin.

Kraft W, Greenberg HE, Waldman SA. Kraft W, et al. Among authors: waldman sa. J Clin Pharmacol. 1998 Mar;38(3):283-6. doi: 10.1002/j.1552-4604.1998.tb04426.x. J Clin Pharmacol. 1998. PMID: 9549667

7

Effect of multiple doses of rifampin on the [14C N-methyl] erythromycin breath test in healthy male volunteers.

Gharaibeh MN, Gillen LP, Osborne B, Schwartz JI, Waldman SA. Gharaibeh MN, et al. Among authors: waldman sa. J Clin Pharmacol. 1998 Jun;38(6):492-5. doi: 10.1002/j.1552-4604.1998.tb05785.x. J Clin Pharmacol. 1998. PMID: 9650537 Clinical Trial.

8

The Molecular Therapeutics Section of the American Society for Clinical Pharmacology and Therapeutics.

Waldman SA, Terzic A. Waldman SA, et al. Clin Pharmacol Ther. 1999 Oct;66(4):336-7. doi: 10.1053/cp.1999.v66.a100878. Clin Pharmacol Ther. 1999. PMID: 10546916 No abstract available.

9

Pharmacokinetics and safety of single intravenous infusions of the adenosine agonist, AMP 579, in patients with end-stage renal insufficiency.

Zannikos PN, Jensen BK, Boutouyrie BX, Tripp L, Yongyi L, McGowan T, Waldman SA, Greenberg HE. Zannikos PN, et al. Among authors: waldman sa. J Clin Pharmacol. 2000 Jul;40(7):745-51. doi: 10.1177/00912700022009503. J Clin Pharmacol. 2000. PMID: 10883416 Clinical Trial.

10

Simvastatin does not affect CYP3A activity, quantified by the erythromycin breath test and oral midazolam pharmacokinetics, in healthy male subjects.

Prueksaritanont T, Vega JM, Rogers JD, Gagliano K, Greenberg HE, Gillen L, Brucker MJ, McLoughlin D, Wong PH, Waldman SA. Prueksaritanont T, et al. Among authors: waldman sa. J Clin Pharmacol. 2000 Nov;40(11):1274-9. J Clin Pharmacol. 2000. PMID: 11075313 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

384 results

Search Page

Filters